Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

摘要

BackgroundIn clinical practice, patients with postmenopausal osteoporosis have often shown a poor response to treatment with an antiresorptive agent for several years. The purpose of this study was to investigate the efficacy of switching raloxifene with minodronate in patients who responded poorly to the treatment of postmenopausal osteoporosis with raloxifene.